BERSKATRYM Trademark

Trademark Overview

On Friday, June 3, 2022, a trademark application was filed for BERSKATRYM with the United States Patent and Trademark Office. The USPTO has given the BERSKATRYM trademark a serial number of 79344839. The federal status of this trademark filing is REGISTERED as of Tuesday, July 4, 2023. This trademark is owned by MERCK KGaA. The BERSKATRYM trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cancer
berskatrym

General Information

Serial Number79344839
Word MarkBERSKATRYM
Filing DateFriday, June 3, 2022
Status700 - REGISTERED
Status DateTuesday, July 4, 2023
Registration Number7095560
Registration DateTuesday, July 4, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 18, 2023

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of cancer
Translation of Words in MarkThe wording ¿BERSKATRYM¿ has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, July 20, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMERCK KGaA
Party Type30 - Original Registrant
Legal Entity Type31 - NOT AVAILABLE
AddressDE
Party NameMERCK KGaA
Party Type20 - Owner at Publication
Legal Entity Type31 - NOT AVAILABLE
AddressDE
Party NameMERCK KGaA
Party Type10 - Original Applicant
Legal Entity Type31 - NOT AVAILABLE
AddressDE

Trademark Events

Event DateEvent Description
Tuesday, October 31, 2023FINAL DECISION TRANSACTION PROCESSED BY IB
Tuesday, October 10, 2023FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, October 10, 2023FINAL DISPOSITION PROCESSED
Wednesday, October 4, 2023FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, July 4, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, July 4, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, April 25, 2023NOTIFICATION PROCESSED BY IB
Tuesday, April 18, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 18, 2023PUBLISHED FOR OPPOSITION
Wednesday, April 5, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, April 5, 2023NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, March 29, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, March 15, 2023REFUSAL PROCESSED BY IB
Tuesday, March 14, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 14, 2023EXAMINER'S AMENDMENT ENTERED
Tuesday, March 14, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, March 14, 2023EXAMINERS AMENDMENT E-MAILED
Tuesday, March 14, 2023EXAMINERS AMENDMENT -WRITTEN
Saturday, March 11, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, March 9, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 9, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, February 17, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, February 17, 2023REFUSAL PROCESSED BY MPU
Thursday, December 22, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, December 21, 2022NON-FINAL ACTION WRITTEN
Wednesday, December 21, 2022ASSIGNED TO EXAMINER
Tuesday, July 26, 2022APPLICATION FILING RECEIPT MAILED
Wednesday, July 20, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, July 19, 2022LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, July 14, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

berskatrym cancer treatment preparations pharmaceutical